This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

International In-house Counsel Journal logoInternational In-house Counsel Journal logo
Back to library search

Attorney-Client Privilege: Application of the Community of Interest Doctrine Exception to Third Party Communications for Licensor-Licensee and Similar Relationships

Abstract

Attorney-client privilege is usually waived if privileged information is disclosed to a third party. Corporations and universities face complicated privilege issues because of a need to sometimes share privileged information with other entities. The community of interest doctrine is an exception to the general attorney-client privilege in that it allows for disclosure of confidential information to a third party without waiving privilege. However, the doctrine has limited applicability and generally only covers situations where the third party has sufficient community of legal interest with the disclosing party. This article provides a description for in-house counsel as to situations where the community of interest exception can be applied to a third party, particularly regarding patent preparation and prosecution, patent litigation, licensing discussions and negotiations, and intellectual property due diligence for licensing and mergers and acquisitions. The article further provides suggestions for protecting privileged information to reduce the risk that the community of interest doctrine will not be applied.

Authors

Portrait image of Rodney Sparks
Rodney Sparks
Senior Biotechnology Patent Counsel, University of Virginia Licensing & Ventures Group, USA

Rodney L. Sparks, J.D., Ph.D. joined the University of Virginia Licensing & Ventures Group in 2004 from the well known intellectual property group at Drinker Biddle & Reath LLP, in Philadelphia. His practice concentrated on biotechnology, pharmaceutical and chemical patent issues, including medicine and gene therapy. He has represented a variety of clients in the United States and abroad, including universities, biotechnology companies, and pharmaceutical companies. Prior to working at Drinker, he was also in private practice at Morgan, Lewis and Bockius LLP, and at Akin, Gump, Strauss, Hauer and Feld, both in Philadelphia. After completing work on his Ph.D., Dr. Sparks completed postdoctoral training in the cellular and molecular biology of cancer at the Johns Hopkins University and at the Mayo Clinic. He was on the faculty of the Oregon Health Sciences University School of Medicine and was a tenured faculty member of Tulane Medical School. While on the faculty at Tulane, he graduated from the evening program of the Loyola University School of Law. Dr. Sparks’ current focus includes overseeing outside patent counsel, drafting and prosecuting patents in the pharmaceutical and biological sciences, preparing opinions and providing counseling on patent matters. He also is responsible for providing counsel on government reporting matters for the Licensing and Ventures Group and teaches law students in the Law Student Patent and Licensing Clinic of the University of Virginia School of Law, where he is also a Lecturer. Dr. Sparks is a member of the American Intellectual Property Law Association and belongs to the Biotechnology, Inter Partes Patent Proceedings Committee, Licensing and Management of IP Assets, and Patent-Relations with the PTO committees of that organization. He also is a member of the Association of University Technology Managers. Dr. Sparks has lectured at national and international meetings on various patent and licensing topics, has served in various consulting capacities for several agencies of the U.S. government, and is an adjunct faculty member of the University of Virginia School of Law, teaching a clinic in patent law and licensing. He has served as a judge for the Modern Marvel patent contest sponsored by the U.S. Patent and Trademark Office and InventNow.org. Christopher D. Paschall, Ph.D., CLP is a licensing manager with the University of Virginia Licensing & Ventures Group. He was formerly a licensing associate with Emory University. He is a registered patent agent with the United States Patent and Trademark Office. Paschall received his doctorate in biomedical engineering from the University of Virginia, where his research focused on leukocyte adhesion in inflammatory responses and its application to targeted drug delivery. He also has a bachelor's degree in chemical engineering from the University of Virginia. Prior to graduate school, he worked as a quality control and process engineer at Klockner Pentaplast of America in Gordonsville, Va. At Klockner, he helped implement a company-wide software program to more efficiently manufacture pharmaceutical-grade plastic products.

Companies

University of Virginia Licensing & Ventures Group

The University of Virginia Patent Foundation, doing business as the University of Virginia Licensing & Ventures Group, is responsible for technology transfer at the University of Virginia and licenses and patents intellectual property developed at the university. It advances promising research discoveries to the marketplace through licenses with industry, new venture formation, and other available pathways.

Related Papers

What You Need to Know about the United States International Trade Commission, Unfair Competition, and Protection of Intellectual Property
The United States International Trade Commission (ITC) is a federal administrative agency with investigative and legal powers over trade. It protects the domestic industry of the United States of America...Read more
Portrait image of Rodney Sparks
Rodney Sparks
Senior Biotechnology Patent Counsel, University of Virginia Licensing & Ventures Group, USA
Portrait image of undefined
Unintended Negative Consequences of Joint Ownership of a Patent
When one entity is a joint owner of a patent or pending patent application with another entity, there are many potential negative ramifications as to licensing, ability to enforce a...Read more
Portrait image of Rodney Sparks
Rodney Sparks
Senior Biotechnology Patent Counsel, University of Virginia Licensing & Ventures Group, USA
Patent Strategies for Attenuated Pathogen Vaccines
Malaria is a major health concern for people traveling to and living in malaria-endemic areas, causing 249 million clinical cases and 608,000 deaths in 2022, numbers essentially unchanged over the...Read more
Portrait image of David Dolberg
David Dolberg
Senior Director of Intellectual Property, Sanaria Inc., USA
Ways to Avoid Having your Patents Cellected*
The Court of Appeals for the Federal Circuit caused frustrations when it decided to affirm the U.S. Patent Office’s findings that claims in four patents were unpatentable because they are...Read more
Portrait image of Tom Irving
Tom Irving
Partner, Marbury Law Group, USA
Portrait image of Xiaoguang Michelle Gao
Xiaoguang Michelle Gao
Associate VP - Assistant General Patent Counsel , Eli Lilly and Company, USA
Portrait image of Michelle E. O'Brien
Michelle E. O'Brien
Partner, Marbury Law Group, USA